CypD inhibitor CC-2055 induces antiseizure effects in mouse model of epilepsy
Dec. 7, 2022
A research team based at the University of California, San Diego presented data from a study that evaluated the novel cyclophilin D (CypD) inhibitor CC-2055 in preclinical models of epilepsy.
